Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Recombinant HIV-1 multi-epitope chimeric antige...
Endogenous peptide, involved in vascular contra...
Phytoestrogen, isoflavone found in various plan...
Impurity of omeprazole
Synthetic progestogen; contraceptive.
Endogenous peptide hormone, involved in secreti...
ATP-sensitive K+ channel activator, α-adrenerg...
Raf inhibitor.
β-lactam cephalosporin; penicillin binding pro...
PLK1 inhibitor.
Phenol found in the creosote bush; 5-lipoxygena...
Polyketide; DNMT 1 inhibitor, RNA synthesis inh...
Calcium channel blocker.
c-Raf, Ret, VEGFR2 inhibitor, potential STAT3/5...
Semi-synthetic peptide, melanocortin analog; MC...
β2-adrenergic agonist.
p110α PI3K inhibitor.
Chk1 inhibitor.
Notch inhibitor.